956101-09-0 Usage
Uses
Used in Pharmaceutical Synthesis:
(3R,4S)-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid is used as an intermediate in the synthesis of various drugs. Its unique structure and functional groups make it a valuable component in the development of new pharmaceutical compounds.
Used in Agrochemical Production:
(3R,4S)-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid is also used as a building block in the production of agrochemicals. Its versatility in organic synthesis allows for the creation of compounds with specific properties tailored for agricultural applications.
Used in Organic Synthesis:
(3R,4S)-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid is used as a versatile building block in organic synthesis. Its functional groups, including the tert-butoxycarbonyl and carboxylic acid groups, enable selective reactions and functional group transformations, making it a valuable compound for the development of new organic compounds with various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 956101-09-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,6,1,0 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 956101-09:
(8*9)+(7*5)+(6*6)+(5*1)+(4*0)+(3*1)+(2*0)+(1*9)=160
160 % 10 = 0
So 956101-09-0 is a valid CAS Registry Number.
956101-09-0Relevant articles and documents
Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists
Young, Jonathan R.,Eid, Ronsar,Turner, Cherilyn,DeVita, Robert J.,Kurtz, Marc M.,Tsao, Kwei-Lan C.,Chicchi, Gary G.,Wheeldon, Alan,Carlson, Emma,Mills, Sander G.
, p. 5310 - 5315 (2007)
The preparation and structure-activity-relationships of novel pyrrolidine-carboxamides and oxadiazoles are described. Compounds in this series were found to be potent hNK1 antagonists in vitro and efficacious in vivo with minimal interactions with P450 liver enzymes. Oxadiazole analog 22 was determined to have excellent hNK1 binding affinity, functional activity, and a good PD response in vivo.
HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
-
Paragraph 00432; 00435, (2021/09/04)
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.
